Science & Technology
Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44EY036343-01
Award Ceiling
$2.1M
Award Floor
$2.1M
Close Date
Aug 31, 2026
169 days leftTotal Funding
$2.1M
Expected Awards
1
Posted Date
Sep 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R44EY036343-01
Description
SBIR Phase Phase II award: "Late-stage Pre-clinical Development and GMP Production of a First-in-Class Extended Release IOP-lowering Formulation" awarded to OCULO THERAPY LLC in MEMPHIS, Tennessee. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,081,932. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.